Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer

Abstract Background and Aim Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with an increased risk of extrahepatic morbidity. We compared the incidence of cancers in adults admitted to Queensland hospitals with MASLD with that for the Queensland population and examined...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Elizabeth E Powell, Shruti Roche, Babak Sarraf, Gunter Hartel, Richard Skoien, Barbara Leggett, James O'Beirne, Patricia C Valery
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-07-01
Edice:	JGH Open
Témata:	cirrhosis diabetes extrahepatic cancer liver disease
On-line přístup:	https://doi.org/10.1002/jgh3.70000
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!